Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mould

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Scientific Reports|August 18, 2017
Enhancing Immune Responses to Cancer Vaccines Using Multi-Site InjectionsRobert C Mould, Amanda W K AuYeung, Jacob P van Vloten, et al.
Frontiers in Microbiology|February 8, 2024
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancerLisa A Santry, Jacob P van Vloten, Amanda W K AuYeung, et al.
Cytokine & Growth Factor Reviews|September 7, 2020
Tumour vasculature: Friend or foe of oncolytic viruses?Lisa A Santry, Jacob P van Vloten, Jason P Knapp, et al.
Cancers|December 24, 2021
Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of SurvivinRobert C Mould, Jacob P van Vloten, Amanda W K AuYeung, et al.
Iscience|October 11, 2021
Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and diseaseBryce M Warner, Lisa A Santry, Alexander Leacy, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Scientific Reports|August 18, 2017
Enhancing Immune Responses to Cancer Vaccines Using Multi-Site InjectionsRobert C Mould, Amanda W K AuYeung, Jacob P van Vloten, et al.
Frontiers in Microbiology|February 8, 2024
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancerLisa A Santry, Jacob P van Vloten, Amanda W K AuYeung, et al.
Cytokine & Growth Factor Reviews|September 7, 2020
Tumour vasculature: Friend or foe of oncolytic viruses?Lisa A Santry, Jacob P van Vloten, Jason P Knapp, et al.
Cancers|December 24, 2021
Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of SurvivinRobert C Mould, Jacob P van Vloten, Amanda W K AuYeung, et al.
Iscience|October 11, 2021
Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and diseaseBryce M Warner, Lisa A Santry, Alexander Leacy, et al.
Pageof 2